Concomitant medications and obstructive sleep apnoea
- PMID: 28677266
- PMCID: PMC5595945
- DOI: 10.1111/bcp.13337
Concomitant medications and obstructive sleep apnoea
Keywords: adverse drug reactions; concomitant medications; drug safety; obstructive sleep apnoea; pharmacovigilance.
Comment in
-
Drugs and obstructive sleep apnoea.Br J Clin Pharmacol. 2017 Oct;83(10):2317-2318. doi: 10.1111/bcp.13361. Epub 2017 Jul 14. Br J Clin Pharmacol. 2017. PMID: 28707329 Free PMC article. No abstract available.
Comment on
-
Impact of concomitant medications on obstructive sleep apnoea.Br J Clin Pharmacol. 2017 Apr;83(4):688-708. doi: 10.1111/bcp.13153. Epub 2016 Nov 24. Br J Clin Pharmacol. 2017. PMID: 27735059 Free PMC article. Review.
References
-
- Vial T. French pharmacovigilance: missions, organization and perspectives. Therapie 2016; 71: 143–150. - PubMed
-
- Linselle M, Montastruc F, Jantzen H, Valnet‐Rabier MB, Haramburu F, et al. Drugs and sleep apneas? A review of the French Pharmacovigilance database. Therapie 2015; 70: 347–350. - PubMed
-
- Bate A, Lindquist M, Edwards IR. The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database. Fundam Clin Pharmacol 2008; 22: 127–140. - PubMed
-
- Faillie JL, Montastruc F, Montastruc JL, Pariente A. Pharmacoepidemiology and its input to pharmacovigilance. Therapie 2016; 71: 211–260. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
